[go: up one dir, main page]

IL94448A - Stable frozen-dry composition of ether / ester polymatoporphyrin - Google Patents

Stable frozen-dry composition of ether / ester polymatoporphyrin

Info

Publication number
IL94448A
IL94448A IL9444890A IL9444890A IL94448A IL 94448 A IL94448 A IL 94448A IL 9444890 A IL9444890 A IL 9444890A IL 9444890 A IL9444890 A IL 9444890A IL 94448 A IL94448 A IL 94448A
Authority
IL
Israel
Prior art keywords
freeze
dried
product
solution
phe
Prior art date
Application number
IL9444890A
Other languages
English (en)
Hebrew (he)
Other versions
IL94448A0 (en
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of IL94448A0 publication Critical patent/IL94448A0/xx
Publication of IL94448A publication Critical patent/IL94448A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9444890A 1989-06-14 1990-05-20 Stable frozen-dry composition of ether / ester polymatoporphyrin IL94448A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/366,374 US5059619A (en) 1989-06-14 1989-06-14 Stable freeze-dried polyhematoporphyrin ether/ester

Publications (2)

Publication Number Publication Date
IL94448A0 IL94448A0 (en) 1991-03-10
IL94448A true IL94448A (en) 1994-06-24

Family

ID=23442747

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9444890A IL94448A (en) 1989-06-14 1990-05-20 Stable frozen-dry composition of ether / ester polymatoporphyrin

Country Status (26)

Country Link
US (1) US5059619A (cs)
EP (1) EP0402637B1 (cs)
JP (1) JP3112918B2 (cs)
KR (1) KR0164845B1 (cs)
CN (1) CN1058388C (cs)
AR (1) AR244549A1 (cs)
AT (1) ATE144703T1 (cs)
AU (1) AU625549B2 (cs)
CA (1) CA2018751C (cs)
CZ (1) CZ283309B6 (cs)
DD (1) DD295087A5 (cs)
DE (1) DE69029012T2 (cs)
DK (1) DK0402637T3 (cs)
ES (1) ES2095846T3 (cs)
FI (1) FI101597B1 (cs)
GR (1) GR3021511T3 (cs)
HU (1) HU215522B (cs)
IE (1) IE902137A1 (cs)
IL (1) IL94448A (cs)
NO (1) NO176645C (cs)
NZ (1) NZ233953A (cs)
PL (1) PL164744B1 (cs)
PT (1) PT94344B (cs)
RU (1) RU2019990C1 (cs)
TW (1) TW225475B (cs)
ZA (1) ZA904599B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US5958104A (en) * 1997-09-11 1999-09-28 Nonomura; Arthur M. Methods and compositions for enhancing plant growth
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
KR20080080685A (ko) 2000-11-29 2008-09-04 피씨아이 바이오테크 에이에스 사이토졸 내로의 분자 전달을 위한 광화학적 내부이행
JP4638654B2 (ja) 2000-11-29 2011-02-23 ピーシーアイ バイオテック エイエス ウィルス媒介の細胞質中への分子送達のための光化学的内在化
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
CN103961323B (zh) * 2013-02-05 2017-10-17 浙江海正药业股份有限公司 一种注射用hpph冻干粉针制剂及其制备方法
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2858320A (en) * 1956-04-02 1958-10-28 Baxter Laboratories Inc Stable hematoporphyrin
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
CA1291710C (en) * 1985-04-30 1991-11-05 Jerry C. Bommer Tetrapyrrole therapeutic agents
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy

Also Published As

Publication number Publication date
KR0164845B1 (ko) 1999-01-15
HUT54888A (en) 1991-04-29
KR910000146A (ko) 1991-01-29
NO902634L (no) 1990-12-17
IE902137L (en) 1990-12-14
CA2018751A1 (en) 1990-12-14
FI101597B (fi) 1998-07-31
PT94344A (pt) 1991-02-08
FI101597B1 (fi) 1998-07-31
ES2095846T3 (es) 1997-03-01
DE69029012T2 (de) 1997-02-27
HU903850D0 (en) 1990-11-28
CN1058388C (zh) 2000-11-15
CS9002889A2 (en) 1991-11-12
EP0402637B1 (en) 1996-10-30
NO176645C (no) 1995-05-10
JP3112918B2 (ja) 2000-11-27
DK0402637T3 (da) 1997-04-07
FI902966A0 (fi) 1990-06-13
AU5708990A (en) 1990-12-20
TW225475B (cs) 1994-06-21
EP0402637A2 (en) 1990-12-19
NO176645B (no) 1995-01-30
HU215522B (hu) 1999-01-28
AU625549B2 (en) 1992-07-16
PT94344B (pt) 1997-04-30
AR244549A1 (es) 1993-11-30
PL164744B1 (pl) 1994-10-31
IE902137A1 (en) 1991-01-02
NO902634D0 (no) 1990-06-13
CA2018751C (en) 2001-08-21
CZ283309B6 (cs) 1998-02-18
DD295087A5 (de) 1991-10-24
GR3021511T3 (en) 1997-01-31
ZA904599B (en) 1991-04-24
JPH0331283A (ja) 1991-02-12
EP0402637A3 (en) 1991-04-03
NZ233953A (en) 1992-08-26
IL94448A0 (en) 1991-03-10
DE69029012D1 (de) 1996-12-05
CN1047973A (zh) 1990-12-26
ATE144703T1 (de) 1996-11-15
RU2019990C1 (ru) 1994-09-30
US5059619A (en) 1991-10-22

Similar Documents

Publication Publication Date Title
US5059619A (en) Stable freeze-dried polyhematoporphyrin ether/ester
EP0568323B1 (en) Stable porfimer sodium compositions and methods for their manufacture
AU717181B2 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
PL205982B1 (pl) Liofilizowany preparat zawierający przeciwciała przeciw receptorowi EGF oraz sposób jego otrzymywania
PL201172B1 (pl) Pd-Bakteriofeoforbid, sposób jego wytwarzania, kompozycja farmaceutyczna zawierająca go i jego zastosowanie
RU2157225C2 (ru) Флавано-лигнановая композиция и лекарственное средство на ее основе
CN111848512B (zh) 使用高纯度盐酸罂粟碱制备粉针剂药物组合物
ES2292781T3 (es) Formulacion galenica inyectable para utilizar en un diagnostico o una terapia fotodinamica y su procedimiento de preparacion.
CN111789818A (zh) 注射用盐酸罂粟碱药物组合物及制备方法
CN117098532A (zh) 稳定的吲哚菁绿制剂
CN116997325A (zh) 稳定的吲哚菁绿制剂
Morgan et al. New dyes for photodynamic therapy
WO2022194731A1 (en) Stable formulations of indocyanine green
CN116549673A (zh) 一种白蛋白-近红外荧光染料纳米粒及其制备方法和应用

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired